Pradaxa Bleeding Risk Gets Deeper FDA Scrutiny In Mini-Sentinel Project

A 2012 Sentinel study didn’t find any problems, but FDA wants a closer look now that the dataset has grown.

More from Post-Marketing Regulation & Studies

More from Product Reviews